NIVF NewGenIvf Group Limited - Class A Ordinary Shares

NASDAQ · Health Care
$0.53
Price · Aug 19, 2026
52W Range
$0–$3
5% of range
Analyst Rating
—
Price Target
$42
+7831% upside
P/E (TTM)
—
ROE
—
Net Profit Margin
—

NIVF Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price
$0.53
Market Cap
—
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
—
Div Yield
—
ROE
—
Debt/Equity
—
52W Range
$0 – $3

NIVF Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income —
EPS —
Free Cash Flow —
Margins —

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric
5Y trend
NIVF
Peer Median

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric
5Y trend
NIVF
Peer Median

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric
5Y trend
NIVF
Peer Median

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric
5Y trend
NIVF
Peer Median

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric
5Y trend
NIVF
Peer Median

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric
5Y trend
NIVF
Peer Median

NIVF Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

12-Month Price Target

1 analysts · 2026-08-14
Median target $42.36 +7831.1%
Mean target $42.36 +7831.1%

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Company insiders 2 insiders · 0 officers · 2 directors

Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Wing Fung Alfred Siu Director June 4, 2026 M 56,881 0 0 $0
Hei Yue Tina Fong Director June 4, 2026 M 56,890 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

Activists & 5%+ owners 1 position

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
Wing Fung Alfred Siu, Hei Yue Tina Fong ×2 filings June 8, 2026 2.80% Amendment — SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.